KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $3.9 billion.

  • Merck's Cost of Revenue fell 551.47% to $3.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 billion, marking a year-over-year decrease of 404.53%. This contributed to the annual value of $15.2 billion for FY2024, which is 578.57% down from last year.
  • Latest data reveals that Merck reported Cost of Revenue of $3.9 billion as of Q3 2025, which was down 551.47% from $3.6 billion recorded in Q2 2025.
  • Merck's Cost of Revenue's 5-year high stood at $5.4 billion during Q1 2022, with a 5-year trough of $3.1 billion in Q2 2021.
  • For the 5-year period, Merck's Cost of Revenue averaged around $3.9 billion, with its median value being $3.9 billion (2021).
  • In the last 5 years, Merck's Cost of Revenue soared by 6817.76% in 2022 and then crashed by 2702.6% in 2023.
  • Merck's Cost of Revenue (Quarter) stood at $3.9 billion in 2021, then grew by 0.18% to $3.9 billion in 2022, then rose by 0.8% to $3.9 billion in 2023, then decreased by 2.15% to $3.8 billion in 2024, then rose by 0.71% to $3.9 billion in 2025.
  • Its last three reported values are $3.9 billion in Q3 2025, $3.6 billion for Q2 2025, and $3.4 billion during Q1 2025.